Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection

Part of paid clinical trials in Austin, Texas.

Sponsor
Natera, Inc.
Study ID
NCT06620627
Status
Recruiting
Apply to this trial

Conditions

  • Colorectal Cancer Screening

Eligibility Criteria

Sex
ALL
Age
40 Years - N/A
Healthy Volunteers
Accepted

Study Details

The PROCEED-CRC study will prospectively collect blood samples from participants who are at average risk of colorectal cancer (CRC). Samples will be used for research use and the development of a blood-based CRC screening test.

Key Dates

First listed
Oct 1, 2024
Start date
Jan 26, 2024
Status verified
Jan 2025
Primary completion
Jul 31, 2025
Completion
Oct 31, 2025

Study Design

Enrollment
5,000 participants (estimated)

Arms

  • Arm: Participants at average risk for colorectal cancer
    Participants 40 years of age or older at time of consent, planning or intending to undergo asymptomatic screening colonoscopy.

Primary Outcome Measure

Primary Objective [ Time Frame: 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
NateraAustinTexas78753
Adham Jurdi, MD
[email protected]
650-489-9050

Find similar trials in Austin, TX

By research site
Natera· Austin, TX

Related Studies